Renal Denervation for Resistant Hypertension

Progress in Cardiovascular Diseases

Volumn 59, Issue 3, 2016, Pages 295-302

  Reilly, John P ^a   White, Christopher J ^a,b  

^a JOHN OCHSNER HEART AND VASCULAR INSTITUTE   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Anti hypertensive agents; Denervation; Hypertension; Sympathectomy

Indexed keywords

BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL WALL; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); ELECTRODE; FOLLOW UP; GUIDING CATHETER; HUMAN; INFUSION SYSTEM; KIDNEY DENERVATION; KIDNEY DENERVATION SYSTEM; MORBIDITY; ONE SHOT DENERVATION SYSTEM; RADIANCE SYSTEM; RADIOFREQUENCY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESISTANT HYPERTENSION; REVIEW; RISK ASSESSMENT; RISK REDUCTION; TREATMENT OUTCOME; HYPERTENSION; INNERVATION; KIDNEY; PATHOPHYSIOLOGY; PROCEDURES; SYMPATHECTOMY;

CLINICAL TRIALS AS TOPIC; HUMANS; HYPERTENSION; KIDNEY; SYMPATHECTOMY;

EID: 85003952261     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2016.10.003     Document Type: Review

References (19)

1. 1. Mozaffarian, D., Benjamin, E.J., Go, A.S., et al. Heart disease and stroke statistics—2015 update: a report from the american heart association. Circulation 131 (2015), e29–322.
2. 2. Persell, S.D., Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension 57 (2011), 1076–1080.
3. 3. Smith, P.A., Graham, L.N., Mackintosh, A.F., Stoker, J.B., Mary, D.A., Relationship between central sympathetic activity and stages of human hypertension. Am J Hypertens 17 (2004), 217–222.
4. 4. Tsioufis, C., Kordalis, A., Flessas, D., et al. Pathophysiology of resistant hypertension: the role of sympathetic nervous system. Int J Hypertens, 2011, 2011, 642416.
5. 5. Atherton, D.S., Deep, N.L., Mendelsohn, F.O., Micro-anatomy of the renal sympathetic nervous system: a human postmortem histologic study. Clin Anat 25 (2012), 628–633.
6. 6. Sakakura, K., Ladich, E., Cheng, Q., et al. Anatomic assessment of sympathetic peri-arterial renal nerves in man. J Am Coll Cardiol 64 (2014), 635–643.
7. 7. Smithwick, R.H., Thompson, J.E., Splanchnicectomy for essential hypertension; results in 1,266 cases. JAMA 152 (1953), 1501–1504.
8. 8. Peet, M.M., Results of bilateral supradiaphragmatic splanchnicectomy for arterial hypertension. N Engl J Med 236 (1947), 270–277.
9. 9. Gewirtz, J.R., Bisognano, J.D., Catheter-based renal sympathetic denervation: a targeted approach to resistant hypertension. Cartogr J 18 (2011), 97–102.
10. 10. Stefanadis, C., Synetos, A., Toutouzas, K., et al. New double balloon delivery catheter for chemical denervation of the renal artery with vincristine. Int J Cardiol 168 (2013), 4346–4348.
11. 11. Stefanadis, C., Toutouzas, K., Vlachopoulos, C., et al. Chemical denervation of the renal artery with vincristine for the treatment of resistant arterial hypertension: first-in-man application. Hell J Cardiol 54 (2013), 318–321.
12. 12. Fischell, T.A., Ebner, A., Gallo, S., et al. Transcatheter alcohol-mediated perivascular renal denervation with the peregrine system: first-in-human experience. JACC Cardiovasc Interv 9 (2016), 589–598.
13. 13. Neuzil, P., Ormiston, J., Brinton, T.J., et al. Externally delivered focused ultrasound for renal denervation. JACC Cardiovasc Interv 9 (2016), 1292–1299.
14. 14. Krum, H., Schlaich, M., Whitbourn, R., et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373 (2009), 1275–1281.
15. 15. Symplicity, H.T.N.I., Esler, M.D., Krum, H., et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (the symplicity htn-2 trial): a randomised controlled trial. Lancet 376 (2010), 1903–1909.
16. 16. Esler, M.D., Krum, H., Schlaich, M., et al. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the symplicity htn-2 randomized, controlled trial. Circulation 126 (2012), 2976–2982.
17. 17. Bhatt, D.L., Kandzari, D.E., O'Neill, W.W., et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 370 (2014), 1393–1401.
18. 18. Kandzari, D.E., Bhatt, D.L., Brar, S., et al. Predictors of blood pressure response in the symplicity htn-3 trial. Eur Heart J 36 (2015), 219–227.
19. 19. Azizi, M., Sapoval, M., Gosse, P., et al. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (denerhtn): a multicentre, open-label, randomised controlled trial. Lancet 385 (2015), 1957–1965.